Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 941636914 | 9416369 | 14 | F | 2003 | 20160802 | 20130724 | 20160822 | PER | US-PFIZER INC-2013212405 | PFIZER | 51.00 | YR | F | Y | 52.00000 | KG | 20160822 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 941636914 | 9416369 | 1 | PS | PREMARIN | ESTROGENS, CONJUGATED | 1 | Oral | 1.25 MG, 1X/DAY | L51266 | 4782 | 1.25 | MG | TABLET | QD | |||||
| 941636914 | 9416369 | 2 | I | PREMARIN | ESTROGENS, CONJUGATED | 1 | Oral | 1.25 MG, 1X/DAY | V122299 | 4782 | 1.25 | MG | TABLET | QD | |||||
| 941636914 | 9416369 | 3 | I | PREMARIN | ESTROGENS, CONJUGATED | 1 | Oral | 1.25 MG, 1X/DAY | H15922 | 4782 | 1.25 | MG | TABLET | QD | |||||
| 941636914 | 9416369 | 4 | I | PREMARIN | ESTROGENS, CONJUGATED | 1 | Oral | 1.25 MG, 1X/DAY | L73753 | 4782 | 1.25 | MG | TABLET | QD | |||||
| 941636914 | 9416369 | 5 | I | PREMARIN | ESTROGENS, CONJUGATED | 1 | Oral | 1.25 MG, 1X/DAY | M54719 | 4782 | 1.25 | MG | TABLET | QD | |||||
| 941636914 | 9416369 | 6 | I | PREMARIN | ESTROGENS, CONJUGATED | 1 | Oral | 0.625 MG, 2X/DAY | 4782 | .625 | MG | TABLET | BID | ||||||
| 941636914 | 9416369 | 7 | I | PREMARIN | ESTROGENS, CONJUGATED | 1 | UNK | H79035 | 4782 | TABLET | |||||||||
| 941636914 | 9416369 | 8 | I | SYNTHROID | LEVOTHYROXINE SODIUM | 1 | Oral | 100 UG , 1X/DAY | 1038881 | 0 | 100 | UG | TABLET | QD | |||||
| 941636914 | 9416369 | 9 | I | SYNTHROID | LEVOTHYROXINE SODIUM | 1 | 100 UG (6 TIMES A WEEK) | 0 | 100 | UG | TABLET | ||||||||
| 941636914 | 9416369 | 10 | C | ASPIRIN. | ASPIRIN | 1 | Oral | 81 MG, 1X/DAY | 0 | 81 | MG | TABLET | QD | ||||||
| 941636914 | 9416369 | 11 | C | VOLTAREN | DICLOFENAC SODIUM | 1 | Topical | 1 + 3/4 INCH STRIP, AS NEEDED | 0 | GEL | |||||||||
| 941636914 | 9416369 | 12 | C | CLONAZEPAM. | CLONAZEPAM | 1 | 1 MG, 1X/DAY | 0 | 1 | MG | TABLET | QD | |||||||
| 941636914 | 9416369 | 13 | C | CLONAZEPAM. | CLONAZEPAM | 1 | 0 | TABLET | |||||||||||
| 941636914 | 9416369 | 14 | C | EVENING PRIMROSE OIL | EVENING PRIMROSE OIL | 1 | 1300 MG, 1X/DAY | 0 | 1300 | MG | QD | ||||||||
| 941636914 | 9416369 | 15 | C | NAPROXEN SODIUM. | NAPROXEN SODIUM | 1 | UNK, AS NEEDED | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 941636914 | 9416369 | 1 | Hormone replacement therapy |
| 941636914 | 9416369 | 2 | Artificial menopause |
| 941636914 | 9416369 | 8 | Hypothyroidism |
| 941636914 | 9416369 | 9 | Hormone replacement therapy |
| 941636914 | 9416369 | 10 | Prophylaxis |
| 941636914 | 9416369 | 11 | Arthritis |
| 941636914 | 9416369 | 12 | Nervous system disorder |
| 941636914 | 9416369 | 13 | Muscle spasms |
| 941636914 | 9416369 | 14 | Arthritis |
| 941636914 | 9416369 | 15 | Arthritis |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 941636914 | 9416369 | Abnormal behaviour | |
| 941636914 | 9416369 | Allergy to plants | |
| 941636914 | 9416369 | Amnesia | |
| 941636914 | 9416369 | Condition aggravated | |
| 941636914 | 9416369 | Depressed mood | |
| 941636914 | 9416369 | Disturbance in attention | |
| 941636914 | 9416369 | Drug dispensing error | |
| 941636914 | 9416369 | Drug effect decreased | |
| 941636914 | 9416369 | Drug ineffective | |
| 941636914 | 9416369 | Drug interaction | |
| 941636914 | 9416369 | Dry skin | |
| 941636914 | 9416369 | Feeling abnormal | |
| 941636914 | 9416369 | Inflammation | |
| 941636914 | 9416369 | Intentional product misuse | |
| 941636914 | 9416369 | Myalgia | |
| 941636914 | 9416369 | Nervous system disorder | |
| 941636914 | 9416369 | Physical product label issue | |
| 941636914 | 9416369 | Product quality issue | |
| 941636914 | 9416369 | Rash | |
| 941636914 | 9416369 | Screaming | |
| 941636914 | 9416369 | Seasonal allergy | |
| 941636914 | 9416369 | Sleep disorder | |
| 941636914 | 9416369 | Suspected counterfeit product | |
| 941636914 | 9416369 | Vulvovaginal dryness | |
| 941636914 | 9416369 | Vulvovaginal pain |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 941636914 | 9416369 | 1 | 1983 | 0 | ||
| 941636914 | 9416369 | 8 | 1983 | 0 | ||
| 941636914 | 9416369 | 11 | 2007 | 0 | ||
| 941636914 | 9416369 | 14 | 2010 | 0 | ||
| 941636914 | 9416369 | 15 | 2007 | 0 |